India, May 15 -- French pharmaceutical firm Sanofi has announced its intention to invest at least$20 billioninthe United States (US)through 2030. The expected investment includes a significant increase in research and development (R&D) spending and the allocation of billions of dollars to US manufacturing.
The announcement comes as Sanofi prepares for the potential launch of numerous new first- or best-in-class medicines across many indications in the coming years, aiming to improve the health of countless Americans.
Work being done withinthe United Statesby Sanofi and by the hundreds of companies it supports is anticipated to contribute to job creation and innovation in numerous communities that are home to Sanofi and its partners, while...